Hussein Ezzeldin, PhD

Associate Director of Advanced Technologies
U.S. Food and Drug Administration

Poster(s):

• (C-248) FDA BEST IM Platform: Accelerating the Automation of Adverse Event Reporting
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET